Avaliação dos níveis de selênio e glutationa peroxidase em pacientes críticos

Authors:
  • NSNeyla Edelwais Silva
    Neyla Edelwais Silva
  • CCCervantes Caporossi
    Cervantes Caporossi
  • ASAlberto Bicudo Salomão
    Alberto Bicudo Salomão
  • DNDiana Borges Dock Nascimento
    Diana Borges Dock Nascimento
  • DMDaniela Alencar Moreira
    Daniela Alencar Moreira

Abstract
Introduction: The ability of selenium to reduce free radicals, associated with its performance as an essential cofactor for glutathione peroxidase, confers a potential role for patients in the intensive care unit. The aim of this study was to evaluate the plasma levels of selenium and glutathione peroxidase at admission and for the period of 7 days of evolution in hospitalized patients. Methods: Observational study with adult patients (n = 22) admitted to the intensive care unit. Three blood samples were taken, on days 1, 3 and 7, to assess selenium, and two for glutathione peroxidase, on days 1 and 7. There was no type of intervention. Results: Selenium levels at admission were below the reference values in half of the patients. When stratifying patients (n = 22) according to the risk of infectious and inflammatory complications (C-reactive protein / albumin ratio), patients classified as high risk had selenium dosage at admission below those of moderate risk (p = 0.032). Among patients with complete follow-up (all dosages were performed), 66.7% were at high risk and among them 75% had selenium below the reference values and below the moderate risk group (p = 0.014). Glutathione peroxidase dosages were normal in all patients, regardless of classification. Conclusion: Approximately 50% of critically ill patients were admitted to the intensive care unit with selenium below the reference values. On admission and progression to the seventh day, patients classified as high risk had selenium dosage below the reference value and below that of patients at moderate risk.